Profound Medical Corp. (PROF): who owns it and who trades it
As of Nov 12, 2026, no open-market insider purchases or sales of PROF were reported in the last 12 months. 1 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 12, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Profound Medical
From the latest filingsOverall: more buying than selling. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns PROF
55 funds and institutions reported PROF shares worth $105M at the end of Q2 2026, about 44% of the company. The largest holder is FIL Ltd with 6.5%.
Funds and institutions (13F) 44%Everyone else 56%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| FIL Ltd | 2.37M | 6.53% | $15.8M | +1% |
| Gagnon Securities LLC | 1.96M | 5.40% | $13M | +1% |
| Royce & Associates LP | 1.20M | 3.31% | $8M | +7% |
| Timelo Investment Management Inc. | 1.11M | 3.07% | $7.4M | No change |
| Gagnon Advisors, LLC | 962,186 | 2.65% | $6.4M | No change |
| Letko, Brosseau & Associates Inc | 935,725 | 2.58% | $5.4M | -2% |
| First Eagle Investment Management, LLC | 880,414 | 2.43% | $5.9M | +173% |
| Rosalind Advisors, Inc. | 828,118 | 2.28% | $5.5M | No change |
| Z3 Capital Partners, LLC | 820,941 | 2.26% | $5.5M | +0% |
| MMCAP International Inc. SPC | 671,356 | 1.85% | $4.5M | -10% |
| Ardsley Advisory Partners LP | 575,000 | 1.58% | $3.8M | No change |
| Lagoda Investment Management, L.P. | 501,325 | 1.38% | $3.3M | +14% |
| Royal Bank of Canada | 491,495 | 1.35% | $3.3M | -0% |
| DAFNA Capital Management LLC | 260,360 | 0.72% | $1.7M | -1% |
| Bleichroeder LP | 254,753 | 0.70% | $1.7M | No change |
| Formula Growth Ltd | 240,088 | 0.66% | $1.6M | -0% |
| National Bank of Canada | 218,698 | 0.60% | $1.2M | +1% |
| Thompson Davis & Co., Inc. | 216,535 | 0.60% | $1.4M | +0% |
| Dauntless Investment Group, LLC | 208,369 | 0.57% | $1.4M | -13% |
| Raymond James Financial Inc | 189,116 | 0.52% | $1.3M | +26% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
No PROF insider reported an open-market purchase or sale in the last 12 months.
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
PROF short interest
Low short interest. 4.3% of PROF shares are sold short: about 1 share in 23. Over the last 12 reports the number of shares short went down 28%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 1.58M PROF shares were sold short, 4.3% of the shares outstanding, up 1.4% from the report before. At the average daily volume of 160,809 shares, buying them all back would take about 9.8 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 1.58M | 4.33% | +1% | 160,809 | 9.8 |
| Oct 15, 2026 | 1.56M | 4.26% | +5% | 482,891 | 3.2 |
| Sep 30, 2026 | 1.48M | 4.06% | -6% | 124,715 | 11.9 |
| Sep 15, 2026 | 1.57M | 4.30% | -3% | 127,446 | 12.3 |
| Aug 31, 2026 | 1.62M | 4.43% | -12% | 111,919 | 14.5 |
| Aug 14, 2026 | 1.84M | 5.04% | +2% | 114,102 | 16.1 |
| Jul 31, 2026 | 1.80M | 4.97% | -3% | 123,068 | 14.7 |
| Jul 15, 2026 | 1.85M | 5.10% | -11% | 98,981 | 18.7 |
| Jun 30, 2026 | 2.07M | 5.70% | -4% | 59,019 | 35.1 |
| Jun 15, 2026 | 2.14M | 5.91% | -3% | 55,163 | 38.9 |
| May 29, 2026 | 2.20M | 6.07% | +1% | 52,727 | 41.8 |
| May 15, 2026 | 2.19M | 6.02% | -6% | 88,781 | 24.6 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Profound Medical company events
Profound Medical filed 37 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership). The latest was on Nov 9, 2026.
- Nov 9, 2026AnnouncementShared information with investors. Filing
- Nov 5, 2026ResultsReleased financial results. Filing
- Nov 3, 2026AgreementProfound Medical (U.S.) Inc., a wholly owned subsidiary of Profound Medical Corp., entered into a Supply and Distribution Agreement with Cook Medical Holdings LLC, effective as of October 23, 2026. Filing
- Oct 22, 2026AnnouncementShared information with investors. Filing
- Oct 14, 2026AnnouncementShared information with investors. Filing
- Oct 9, 2026AnnouncementShared information with investors. Filing
- Oct 7, 2026ResultsReleased financial results. Filing
- Sep 4, 2026AnnouncementShared information with investors. Filing
- Sep 3, 2026LeadershipProfound Medical Corp. announced that Richard R. Fabian has been appointed by the Board of Directors of the Company to serve as the President of the Company, effective as of the same date. Filing
- Aug 17, 2026AnnouncementShared information with investors. Filing
- Aug 17, 2026LeadershipProfound Medical Corp. announced that Matthew Sobczyk has been appointed by the Board of Directors of the Company to serve as the Interim Chief Financial Officer of the Company, effective as of the same date. Filing
- Aug 13, 2026AnnouncementShared information with investors. Filing
- Aug 6, 2026ResultsReleased financial results. Filing
- Jul 24, 2026AnnouncementShared information with investors. Filing
- Jul 16, 2026AnnouncementShared information with investors. Filing
- Jul 15, 2026AnnouncementShared information with investors. Filing
- May 15, 2026VoteReported shareholder vote results. Filing
- May 14, 2026AnnouncementShared information with investors. Filing
- May 7, 2026ResultsReleased financial results. Filing
- Apr 16, 2026AnnouncementShared information with investors. Filing
- Apr 14, 2026AnnouncementShared information with investors. Filing
- Apr 1, 2026AnnouncementShared information with investors. Filing
- Mar 27, 2026AnnouncementShared information with investors. Filing
- Mar 13, 2026AnnouncementShared information with investors. Filing
- Mar 10, 2026LeadershipKris Shah notified the Board of Directors of Profound Medical Corp. of his resignation from the Board, effective immediately. Filing
- Mar 9, 2026AnnouncementShared information with investors. Filing
- Mar 5, 2026ResultsReleased financial results. Filing
- Feb 12, 2026AnnouncementShared information with investors. Filing
- Feb 12, 2026AnnouncementShared information with investors. Filing
- Feb 5, 2026AnnouncementShared information with investors. Filing
- Jan 28, 2026AnnouncementShared information with investors. Filing
- Jan 15, 2026AnnouncementShared information with investors. Filing
- Jan 12, 2026AnnouncementShared information with investors. Filing
- Jan 6, 2026AnnouncementShared information with investors. Filing
- Dec 31, 2025AgreementProfound Medical Corp. entered into a subscription agreement with certain Canadian investors providing for the private placement of an aggregate of 921,428 shares of the Company’s common shares, at a per share purchase price of $7.00 for aggregate gross proceeds of $6.45 million. Filing
- Dec 19, 2025AgreementProfound Medical Corp., entered into a Securities Purchase Agreement with certain investors, pursuant to which the Company agreed to issue and sell to the Purchasers in a registered direct offering an aggregate of 5,142,870 shares of the Company’s common shares, at a price of $7.00 per share, for… Filing
- Nov 28, 2025AnnouncementShared information with investors. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Profound Medical financials
Famous investors that hold PROF
1 of the 50 well-known investors we track reported holding PROF in their latest 13F filing. The largest position is Jim Simons's, worth $67.9K.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 11,700 | $67.9K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Profound Medical Corp. (PROF) stock
Who owns the most PROF stock?
The largest reported owner of Profound Medical Corp. (PROF) is FIL Ltd, with 6.5% of the company. In total, 55 funds and institutions reported holding PROF at the end of Q2 2026, together about 44% of the shares. See the largest owners.
Are PROF insiders buying or selling?
No PROF insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.
What is the short interest in PROF?
As of Oct 30, 2026, 1.58M PROF shares were sold short, 4.3% of the shares outstanding, up 1.4% from the report before. At the average daily volume of 160,809 shares, buying them all back would take about 9.8 trading days (days to cover). See the history.
Which famous investors hold PROF?
1 of the 50 well-known investors we track reported PROF in their latest 13F filing, including Jim Simons. The largest position is worth $67.9K. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.